Showing results (1-10 of 96) with videos related to
Sort By:
Pageof 10
Molecules (Basel, Switzerland)|August 10, 2024
Current Understanding of the Role of Adenosine Receptors in CancerKatharigatta Narayanaswamy Venugopala, Michela BuccioniDrug Discovery Today|August 17, 2025
Beyond purinergic signaling: Dual ligand approaches to multitarget drug discoveryBeatrice Francucci, Aleksei Smirnov, Andrea Spinaci, et al.Biofactors (Oxford, England)|August 18, 2022
The possible role of the nucleoside adenosine in countering skin aging: A reviewGabriella Marucci, Michela Buccioni, Vincenzo Varlaro, et al.In Silico Pharmacology|December 16, 2014
Simulation and comparative analysis of binding modes of nucleoside and non-nucleoside agonists at the A2B adenosine receptorDiego Dal Ben, Michela Buccioni, Catia Lambertucci, et al.European Journal of Medicinal Chemistry|December 3, 2014
Purinergic P2X receptors: structural models and analysis of ligand-target interactionDiego Dal Ben, Michela Buccioni, Catia Lambertucci, et al.Current Medicinal Chemistry|December 18, 2014
Medicinal chemistry of P2X receptors: agonists and orthosteric antagonistsCatia Lambertucci, Diego Dal Ben, Michela Buccioni, et al.Neuropharmacology|October 9, 2020
Efficacy of acetylcholinesterase inhibitors in Alzheimer's diseaseGabriella Marucci, Michela Buccioni, Diego Dal Ben, et al.Bioorganic & Medicinal Chemistry|May 23, 2018
Chiral analogues of (+)-cyclazosin as potent α1B-adrenoceptor selective antagonistGianni Sagratini, Michela Buccioni, Gabriella Marucci, et al.Analytical and Bioanalytical Chemistry|September 11, 2012
Development of new chromatographic tools based on A2A adenosine receptor subtype for ligand characterization and screening by FAC-MSCaterina Temporini, Gabriella Massolini, Gabriella Marucci, et al.Farmaco (Societa Chimica Italiana : 1989)|September 19, 2003
Synthesis and antagonistic activity at muscarinic receptor subtypes of some derivatives of diphenidolLucilla Varoli, Piero Angeli, Michela Buccioni, et al.Pageof 10